Mongodb Inc vs Sanofi SA — how do they compare? Mongodb Inc trades at $434.94 (market cap $35.32B), while Sanofi SA trades at $43.51 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 3× Mongodb Inc's market cap, and Sanofi SA pays a 5.55% dividend while Mongodb Inc pays none. Which is the better fit depends on your goals.
| MDB | SNY | |
|---|---|---|
Market Cap | $35.32B | $104.30B |
Sector | Technology | Health |
52-Week High | $440.25 | $52.34 |
52-Week Low | $204.37 | $41.33 |
Enterprise Value | $32.93B | $124.19B |
Dividend Yield | — | 5.55% |
Trailing returns across standard periods
Latest headlines on both assets
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →